Higher doses of empagliflozin are only recommended for which disease?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $25.99Unlock all

Study for the Pharmacology Presentation Drugs Test. Delve into flashcards and multiple choice questions with hints and explanations. Gear up for examination success!

Multiple Choice

Higher doses of empagliflozin are only recommended for which disease?

Explanation:
The key idea is that dosing of empagliflozin is driven by the disease indication. A higher daily dose (25 mg) is approved specifically for type 2 diabetes to boost glycemic control when needed. For heart failure with reduced ejection fraction and for chronic kidney disease, the typical approved dose is 10 mg daily and higher doses aren’t approved or recommended based on current labeling and safety data. In type 1 diabetes, SGLT2 inhibitors like empagliflozin are not approved due to safety concerns, such as a higher risk of ketoacidosis. So, the disease for which a higher dose is recommended is type 2 diabetes.

The key idea is that dosing of empagliflozin is driven by the disease indication. A higher daily dose (25 mg) is approved specifically for type 2 diabetes to boost glycemic control when needed. For heart failure with reduced ejection fraction and for chronic kidney disease, the typical approved dose is 10 mg daily and higher doses aren’t approved or recommended based on current labeling and safety data. In type 1 diabetes, SGLT2 inhibitors like empagliflozin are not approved due to safety concerns, such as a higher risk of ketoacidosis.

So, the disease for which a higher dose is recommended is type 2 diabetes.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy